Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours

C Horbinski, T Berger, RJ Packer, PY Wen - Nature Reviews Neurology, 2022 - nature.com
A new edition of the WHO classification of tumours of the CNS was published in 2021.
Although the previous edition of this classification was published just 5 years earlier, in …

Meningioma: a review of clinicopathological and molecular aspects

K Huntoon, AMS Toland, S Dahiya - Frontiers in oncology, 2020 - frontiersin.org
Meningiomas are the most the common primary brain tumors in adults, representing
approximately a third of all intracranial neoplasms. They classically are found to be more …

Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma

ST Magill, HN Vasudevan, K Seo… - Nature …, 2020 - nature.com
Meningiomas are the most common primary intracranial tumors, but the molecular drivers of
meningioma tumorigenesis are poorly understood. We hypothesized that investigating …

Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomas

MW Youngblood, Z Erson-Omay, C Li, H Najem… - Nature …, 2023 - nature.com
Hedgehog signaling mediates embryologic development of the central nervous system and
other tissues and is frequently hijacked by neoplasia to facilitate uncontrolled cellular …

An overview of managements in meningiomas

L Zhao, W Zhao, Y Hou, C Wen, J Wang, P Wu… - Frontiers in …, 2020 - frontiersin.org
Meningioma is the most frequent primary tumor of the central nervous system. Important
advances have been achieved in the treatment of meningioma in recent decades. Although …

Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features

A Choudhury, WC Chen, CHG Lucas… - Neuro …, 2023 - academic.oup.com
Background Meningiomas, the most common primary intracranial tumors, can be separated
into 3 DNA methylation groups with distinct biological drivers, clinical outcomes, and …

Perivascular NOTCH3+ Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy

A Choudhury, MA Cady, CHG Lucas, H Najem… - Cancer …, 2024 - aacrjournals.org
Meningiomas are the most common primary intracranial tumors. Treatments for patients with
meningiomas are limited to surgery and radiotherapy, and systemic therapies remain …

The Role of [68Ga]Ga-DOTA-SSTR PET Radiotracers in Brain Tumors: A Systematic Review of the Literature and Ongoing Clinical Trials

P Palmisciano, G Watanabe, A Conching… - Cancers, 2022 - mdpi.com
Simple Summary [68Ga] Ga-DOTA-SSTR PET imaging has recently been introduced in the
management of patients with brain tumors, mostly meningiomas and pituitary adenomas or …

H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort

F Behling, C Fodi, I Gepfner-Tuma… - Neuro …, 2021 - academic.oup.com
Background A loss of the trimethylation of lysine 27 of histone H3 (H3K27me3) in
meningioma has been recently suggested as an adjunct to identify subsets of higher risk of …

WHO grade I meningioma recurrence: identifying high risk patients using histopathological features and the MIB-1 index

AF Haddad, JS Young, I Kanungo, S Sudhir… - Frontiers in …, 2020 - frontiersin.org
Objective: In this study, we identify clinical, radiographic, and histopathologic
prognosticators of overall, early, and post-median recurrence in World Health Organization …